VentiRx Pharmaceuticals

VentiRx Pharmaceuticals is a clinical-stage biopharmaceutical company dedicated to the development and commercialization of drugs for the treatment of cancer, respiratory diseases, and autoimmune diseases. The company focuses on developing small-molecule product candidates targeting toll-like receptor 8 (TLR8) agonists and antagonists.